Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1952 2
1953 5
1954 3
1955 9
1956 5
1957 4
1958 8
1959 5
1965 3
1966 6
1967 20
1968 21
1969 34
1970 69
1971 92
1972 70
1973 58
1974 46
1975 36
1976 38
1977 37
1978 27
1979 38
1980 49
1981 31
1982 35
1983 31
1984 35
1985 45
1986 41
1987 60
1988 42
1989 45
1990 47
1991 66
1992 44
1993 26
1994 42
1995 36
1996 33
1997 40
1998 37
1999 53
2000 69
2001 65
2002 65
2003 107
2004 113
2005 122
2006 118
2007 140
2008 128
2009 118
2010 137
2011 140
2012 158
2013 156
2014 135
2015 121
2016 133
2017 126
2018 120
2019 70
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

3,592 results
Results by year
Filters applied: . Clear all
Page 1
Amantadine.
Parkes D. Parkes D. Adv Drug Res. 1974;8:11-81. Adv Drug Res. 1974. PMID: 4219097 Review. No abstract available.
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.
Sani G, Serra G, Kotzalidis GD, Romano S, Tamorri SM, Manfredi G, Caloro M, Telesforo CL, Caltagirone SS, Panaccione I, Simonetti A, Demontis F, Serra G, Girardi P. Sani G, et al. CNS Drugs. 2012 Aug 1;26(8):663-90. doi: 10.2165/11634390-000000000-00000. CNS Drugs. 2012. PMID: 22784018 Review.
Pacritinib: a new agent for the management of myelofibrosis?
Beauverd Y, McLornan DP, Harrison CN. Beauverd Y, et al. Expert Opin Pharmacother. 2015;16(15):2381-90. doi: 10.1517/14656566.2015.1088831. Expert Opin Pharmacother. 2015. PMID: 26389774 Review.
Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
Kulkarni J, Thomas N, Hudaib AR, Gavrilidis E, Grigg J, Tan R, Cheng J, Arnold A, Gurvich C. Kulkarni J, et al. CNS Drugs. 2018 Feb;32(2):179-187. doi: 10.1007/s40263-018-0506-8. CNS Drugs. 2018. PMID: 29549516 Clinical Trial.
Pacritinib Bests Available Therapies for Myelofibrosis.
Cancer Discov. 2015 Jul;5(7):OF7. doi: 10.1158/2159-8290.CD-NB2015-080. Epub 2015 Jun 1. Cancer Discov. 2015. PMID: 26034055 Free article. No abstract available.
The role of pacritinib in the management of myelofibrosis.
Duong VH, Komrokji RS. Duong VH, et al. Expert Rev Hematol. 2014 Jun;7(3):325-32. doi: 10.1586/17474086.2014.905200. Epub 2014 Apr 21. Expert Rev Hematol. 2014. PMID: 24746271
3,592 results
Jump to page
Feedback